Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenbin Xiao

Showing results (81-90 of 108) with videos related to

Pageof 11
Sort By:
Journal of Hematology & Oncology|July 15, 2025
Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AMLBrian J Ball, Wenbin Xiao, Gautam Borthakur, et al.
Blood|April 14, 2022
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformationBing Li, Wenbin An, Hua Wang, et al.
Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
Blood|January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotypePallavi Galera, Deepika Dilip, Andriy Derkach, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
Blood Advances|March 9, 2021
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AMLMaximilian Stahl, Kamal Menghrajani, Andriy Derkach, et al.
Cell Stem Cell|September 10, 2019
Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and DifferentiationAaron D Viny, Robert L Bowman, Yu Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric studyMingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Blood Advances|December 12, 2018
<i>PHF6</i> and <i>DNMT3A</i> mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiationWenbin Xiao, Maheetha Bharadwaj, Max Levine, et al.
Cancer Discovery|July 17, 2020
PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2<sup>V617F</sup>-Mutant MPNFriederike Pastore, Neha Bhagwat, Alessandro Pastore, et al.
Pageof 11

Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
Journal of Hematology & Oncology|July 15, 2025
Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AMLBrian J Ball, Wenbin Xiao, Gautam Borthakur, et al.
Blood|April 14, 2022
BMP2/SMAD pathway activation in JAK2/p53-mutant megakaryocyte/erythroid progenitors promotes leukemic transformationBing Li, Wenbin An, Hua Wang, et al.
Blood Advances|May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasmsNatasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
Blood|January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotypePallavi Galera, Deepika Dilip, Andriy Derkach, et al.
Blood Advances|December 26, 2023
High-risk and silent clonal hematopoietic genotypes in patients with nonhematologic cancerAaron J Stonestrom, Kamal N Menghrajani, Sean M Devlin, et al.
Blood Advances|March 9, 2021
Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AMLMaximilian Stahl, Kamal Menghrajani, Andriy Derkach, et al.
Cell Stem Cell|September 10, 2019
Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and DifferentiationAaron D Viny, Robert L Bowman, Yu Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Genetic risk and immune dysregulation of classic Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma: a multicentric studyMingfei Yan, Sameer A Parikh, Michelly K Sampaio De Melo, et al.
Blood Advances|December 12, 2018
<i>PHF6</i> and <i>DNMT3A</i> mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiationWenbin Xiao, Maheetha Bharadwaj, Max Levine, et al.
Cancer Discovery|July 17, 2020
PRMT5 Inhibition Modulates E2F1 Methylation and Gene-Regulatory Networks Leading to Therapeutic Efficacy in JAK2<sup>V617F</sup>-Mutant MPNFriederike Pastore, Neha Bhagwat, Alessandro Pastore, et al.
Pageof 11